COMMUNIQUÉS West-GlobeNewswire

Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon

23/01/2025 - 17:00

Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment ROSELAND, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading [...]

Medisensonic S.A. Modern medical technologies with growing investment potential

23/01/2025 - 16:26

WARSAW, Poland, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Medisensonic S.A., a Polish MedTech joint-stock company with an estimated market value of more than €15 million, is one of the very promising players in the market. The [...]

Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer

23/01/2025 - 15:42

Industry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- [...]

LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)

23/01/2025 - 15:15

LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases. Topline Phase 1 clinical data for LPX- [...]

DLH to Announce Fiscal 2025 First Quarter Financial Results

23/01/2025 - 15:12

ATLANTA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]

Outlook Therapeutics® Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD

23/01/2025 - 15:05

Data presented at Hawaiian Eye and Retina 2025 Meeting Results confirmed that intravitreal ONS-5010 provided early and sustained anatomic improvements, with steady gains in BCVA and reliable, consistent safety ONS-5010 [...]

PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider

23/01/2025 - 15:05

MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at [...]

Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic

23/01/2025 - 15:00

- Up to 200 subjects will receive four curated strains never before given in combination as a synbiotic treatment, as part of a development plan to improve infant health outcomes - SAN DIEGO, Jan. 23, 2025 (GLOBE [...]

PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions

23/01/2025 - 15:00

Collaboration Marks First At-Scale Deployment of AI Technologies into Leading Commercial Biobank BOSTON and HUNTSVILLE, Ala, Jan. 23, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered technology for [...]

Tiziana Life Sciences not to engage in capital raising activities for the immediate future

23/01/2025 - 14:54

NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]

AIM ImmunoTech Announces Publication of Final Clinical Study Results for AMP-518 Clinical Trial on Ampligen as a Therapeutic for Post-COVID Conditions

23/01/2025 - 14:50

OCALA, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety [...]

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

23/01/2025 - 14:30

Conference call and webcast scheduled to take place on Wednesday, February 5, 2025, at 4:30 p.m. E.T. SCOTTSDALE, Ariz., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), [...]

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

23/01/2025 - 14:30

SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing comprehensive information [...]

Safety Shot Reaches an Amicable Litigation Settlement Agreement, Strengthening Financial Position and Fostering Strategic Partnerships

23/01/2025 - 14:30

SCOTTSDALE, Ariz., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today announced that it has reached a settlement [...]

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome

23/01/2025 - 14:30

Four Weeks After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured Endpoints Observed Data Supports QRX003 Mechanism of Action as a Competitive Broad [...]

Inteleos Foundation Announces Two New Global Health Leaders to 2025 Board Directors

23/01/2025 - 14:15

ROCKVILLE, Md., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Inteleos Foundation, an international nonprofit organization driving access to medical imaging, has announced the addition of two esteemed members to the Board of [...]

SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia

23/01/2025 - 14:10

- REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical Trial Without [...]

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

23/01/2025 - 14:03

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most Successful Mid-Cap [...]

AMN Healthcare to Hold Fourth Quarter and Full Year 2024 Earnings Conference Call on Thursday, February 20, 2025

23/01/2025 - 14:00

DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2024 financial results and first quarter 2025 outlook on [...]